Nomis Bay Opportunity

Nomis Bay Opportunity is a private investment firm specializing in the life sciences and healthcare sectors. The firm provides flexible capital solutions, including royalty-backed financing, senior secured debt, and strategic equity investments to biopharmaceutical and medical technology companies. It is managed by EOM Management Ltd. and is notably involved in the acquisition of royalty interests for commercialized assets, such as the filgotinib (Jyseleca) portfolio acquired from Galapagos. Nomis Bay Opportunity frequently participates in structured financing deals, providing non-dilutive funding to companies like Pelthos Therapeutics and Tivic Health. By focusing on late-stage and commercial assets, the firm helps healthcare companies navigate the capital-intensive phases of product launch and expansion.